![Michael P. Graziano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael P. Graziano
No más puestos en curso
Perfil
Michael P.
Graziano is the founder of Institute For Life Science Entrepreneurship.
He worked as Vice President-Research Biology at MyoKardia, Inc. and as Head-Cardiometabolic Drug Discovery at Schering-Plough Research Institute from 1995 to 2008.
Graziano received his undergraduate degree from New York University and his doctorate from The State University of New York.
Antiguos cargos conocidos de Michael P. Graziano.
Empresas | Cargo | Fin |
---|---|---|
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 01/01/2008 |
Institute For Life Science Entrepreneurship
![]() Institute For Life Science Entrepreneurship Miscellaneous Commercial ServicesCommercial Services The Institute for Life Science Entrepreneurship is a leading innovation center in the life science industry. The private company is based in Union and was founded by Michael P. Graziano. The American company specializes in cutting-edge microbiology research and services, as well as disruptive innovation in translational neuroscience. | Fundador | - |
MYOKARDIA, INC. | Director Técnico/Científico/I+D | - |
Formación de Michael P. Graziano.
New York University | Undergraduate Degree |
The State University of New York | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
MyoKardia, Inc.
![]() MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
Institute For Life Science Entrepreneurship
![]() Institute For Life Science Entrepreneurship Miscellaneous Commercial ServicesCommercial Services The Institute for Life Science Entrepreneurship is a leading innovation center in the life science industry. The private company is based in Union and was founded by Michael P. Graziano. The American company specializes in cutting-edge microbiology research and services, as well as disruptive innovation in translational neuroscience. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael P. Graziano